glp-1 thyroid Do Weight-Loss Shots Really Raise Cancer Risk? With the rapid expansion of GLP-1 medications for diabetes and weight loss, public concern has grown regarding a possible link to thyroid cancer The Truth About GLP-1s, Thyroid

Luecke-Johansson S, Gralla M, Rundqvist H, Ho JC, Johnson RS, Gradin K, Poellinger L (2017) A molecular mechanism to switch the aryl hydrocarbon receptor from a transcription factor to an E3 ubiquitin ligase

On the other hand, there are also some studies evaluating the gut microbiota composition in relation to the type of BD

Conversely, a decrease in labelling indicates reduced metabolic flux

Importantly, the review also notes that individual responses to incretin-based therapies can vary substantially, and weight regain commonly occurs if treatment is discontinued, highlighting the chronic nature of obesity management

Original Discovery Published McCoy et al